The regulatory (R) subunits of cAMP-dependent protein kinase (PKA) are implicated in the regulation of cell proliferation and dierentiation. There are two isoforms of PKA that are distinguished by two types of R subunit, RI and RII. Evidence suggests that RI is associated with proliferation and RII is associated with cell dierentiation. Previous work in this laboratory has demonstrated that depletion of the RIa subunit by treatment with an antisense oligonucleotide (ODN) induces dierentiation in leukemia cells and growth arrest and apoptosis in epithelial cancer cells. Using the prostate cancer cell line PC3M as a model system, we have developed a cell line that overexpresses a retroviral vector construct containing the RIa antisense gene. This cell line has been characterized and the eectiveness of the construct determined. In the work presented here, we demonstrate by immunocytochemistry that treatment with RIa antisense ODN induces translocation of the Ca subunit of PKA to the nucleus of PC3M prostate cancer cells. The translocation of Ca triggered by exogenous antisense ODN treatment mirrors that observed in cells endogenously overexpressing the antisense gene. Triggering the nuclear translocation of the Ca subunit of PKA in the cell may be an important mechanism of action of RIa antisense that regulates cell growth independent of adenylate cyclase and cellular cAMP levels. The nuclear localization of the Ca subunit of PKA may be an essential step in revealing the mechanism whereby this critical kinase regulates cell growth. Oncogene (2001) 20, 8019± 8024.
Introduction
The cAMP-dependent protein kinase (PKA) is a tetrameric protein comprised of two catalytic (C) subunits and two regulatory (R) subunits. Two types of regulatory subunit, RI and RII, de®ne the type of kinase (PKA-I and PKA-II, Beebe and Corbin, 1986) . Upon binding of cAMP to the R subunit, the holoenzyme dissociates and the C subunit translocates to the nucleus, where it phosphorylates the cAMP response element (CRE) binding protein CREB (Montminy and Bilezikjian, 1987) , which in turn activates the CREB binding protein CBP (Arias et al., 1994) to initiate transcription of genes containing the CRE sequence in their promoters (Montminy et al., 1986; Yamamoto et al., 1988; Kwok et al., 1994; Montminy, 1997) .
Originally, the R subunits of this protein kinase were believed to function as mere cAMP receptors that suppress the activity of the C subunit. However, experimental evidence has implicated the R subunits in the regulation of cell proliferation or dierentiation (Cho-Chung, 1990) , and increased RI expression has been observed in many primary human tumors (Bold et al., 1994; Bradbury et al., 1994; McDaid et al., 1999; Miller et al., 1993a,b; Simpson et al., 1996; Young et al., 1995) . A site-selective cAMP analog that selectively downregulates RIa also inhibits the growth of human carcinomas, ®brosarcomas, and leukemias in vitro and in vivo .
Treatment of the leukemia cell line HL-60 with an antisense oligodeoxynucleotide (ODN) targeted against the mRNA of the PKA RIa subunit downregulates RIa, upregulates RIIb, and causes alterations to the cell morphology consistent with a more dierentiated cell type (Tortora et al., 1991) . In colon carcinoma cells, (LS-174T, , lung carcinoma cells (A549), androgen-dependent prostate adenocarcinoma cells (LNCaP), leukemia cells (Molt-4), and T lymphoma cells (Jurkat), RIa antisense treatment decreases RIa mRNA and protein levels and inhibits cell growth (Nesterova and Cho-Chung, 2000) . The eects of this particular antisense sequence (an RNA/ DNA-mixed backbone [MBO] ODN) are highly speci®c to RIa (Nesterova and Cho-Chung, 2000) . This MBO ODN exhibits increased stability, has reduced nonspeci®c eects such as immunostimulation and cytotoxicity (Zhao et al., 1999; Chen et al., 2000) , and is orally viable (Wang et al., 1999) . Furthermore, in cancer cells containing both RIa and RIIb subunits, RIa antisense ODN treatment activates PKA-I without increasing cAMP levels (Nesterova and Cho-Chung, 2000) and increases the expression of RIIb, even in cancer cells that do not express RIIb at any detectable level (Cho-Chung, 1998) . By restoring control of the cAMP pathway in cancer cells to that of normal cells, the ODN may inhibit growth factor responsiveness, resulting in growth inhibition (Nesterova and ChoChung, 2000) .
Antisense ODNs hold great promise as drugs because of their more speci®c intracellular eects. However, speci®cally downregulating one protein may have unforeseen consequences in multiple cellular signaling pathways. Therefore, it is very important to understand the precise mechanism of action of any antisense ODN in order to more accurately predict its eect on a cell or in vivo system. To that end, we have explored in this study the eect of downregulation of a speci®c R subunit of PKA on the intracellular localization of the catalytic subunit in PC3M prostate cancer cells. We hypothesize that depletion of the RIa subunit resulting from exposure of the cells to antisense may result in an increase in free Ca subunit and thus promote its translocation to the nucleus.
Results

Time course of RIa antisense ODN treatment-induced translocation of Ca in PC3M cells
To examine the eect of RIa antisense on Ca localization in PC3M prostate cancer cells, a time course of exposure to RIa antisense ODN was performed. In untreated cells, Ca was primarily localized to the cytoplasm, with some nuclear staining ( Figure 1a ). The nuclei in these cells were also uniform and ovoid, as expected ( Figure 1b) . In contrast, cells transfected with antisense ODN showed altered staining patterns after 2 days (Figure 1c,d) . After 1 day, there was no alteration in the Ca staining (data not shown), but after 2 days, the amount of Ca staining in the nucleus had increased. Ca localization was still primarily cytoplasmic at this time, and the nuclei were uniform and ovoid with only slight irregularities. After 3 days, Ca staining was distributed evenly throughout the cell, including the nucleus (Figure 1e,f) . After 5 days, Ca staining still appeared in both the nucleus and cytoplasm, but the intensity had decreased overall (Figure 1g,h ).
The sequence-specific effects of RIa antisense ODN on the intracellular localization of Ca
To determine whether translocation of Ca resulted from a sequence-speci®c eect of the RIa antisense or a nonspeci®c eect of exposure to ODNs, we treated PC3M cells with either RIa antisense or a control (random or mismatched) ODN. Untreated PC3M cells showed bright Ca staining in the cytoplasm (refer to Figure 1a ,b). A 3-day treatment with 0.2 mM RIa antisense induced nuclear translocation of Ca ( Figure  2c ). Nuclear Ca staining was not exclusive ± there was still signi®cant cytoplasmic staining. In contrast, treatment with 0.2 mM control ODN had no signi®cant eect on Ca staining ( Figure 2a) ; Ca staining was still primarily cytoplasmic. These results indicate that the RIa antisense eect is sequence speci®c and not the result of a nonspeci®c eect of ODN exposure (Levin, 1999) .
Overexpression of RIa antisense gene in PC3M cells alters the intracellular localization of Ca
In addition to treating cells with RIa antisense ODN, we have stably transfected PC3M cells with the MTRIa antisense vector, which contains the RIa cDNA (the N-terminal 210 nucleotides) in the antisense (Cho et al., 2001) . This system avoids the problems inherent in oligonucleotide treatment, namely the delivery and stability of the oligonucleotide. In parental PC3M cells, the Ca was located primarily in the cytoplasm (data not shown, refer to Figure 1a) , and 3 days of ZnSO 4 (80 mM) treatment did not alter this localization (Figure 3a) . Strikingly, in PC3M cells transfected with RIa antisense gene, there was a marked increase in Ca nuclear staining (Figure 3c ).
Treatment with forskolin induces a similar, but not identical, translocation of Ca
As a positive control for nuclear translocation of Ca, PC3M cells were treated with forskolin, a small cell permeant drug that activates adenylate cyclase, thereby increasing intracellular levels of cAMP (Seamon et al., 1981) . After DMSO treatment, Ca is found primarily in the cytoplasm (Figure 4a ) as is seen in the untreated PC3M cells. Following treatment with 10 mM forskolin for 1 h, Ca staining was observed primarily in the nucleus, with very little staining in the cytoplasm (Figure 4c ). This localization persisted even after an overnight exposure (data not shown). As the time of forskolin exposure increased, the staining intensity decreased. These results clearly demonstrate that translocation of the C subunit can be visualized by immunocytochemistry and that RIa antisense exposure induces a translocation that is similar to that occurring after activation of PKA by a forskolininduced increase in cellular cAMP levels. Comparison of Ca staining after exposure to either RIa AS ODN or a control ODN. PC3M cells were seeded on coverslips as described in Materials and methods. Twelve to fourteen hours after seeding, the medium was removed and replaced with complete RPMI 1640 medium containing antisense ODN (0.2 mM) or control 4-base mismatched or random sequence ODN (0.2 mM) and DOTAP (see Materials and methods). After 10 h of incubation, the medium was removed and replaced with fresh complete RPMI 1640 without antisense, control ODN or DOTAP. After 3 days, the cells were stained as described in ,c) respectively. The data represent one of two independent experiments that gave similar results. Forskolin was added to the medium in the dishes at a ®nal concentration of 10 mM from a stock solution of 1 mM in DMSO. Control dishes had an equivalent amount of DMSO (1%). After incubation for 1 h, the medium was removed and the cells were ®xed and permeabilized as described in the Materials and methods section
Discussion
We have demonstrated that in prostate cancer cells, the Ca subunit of PKA translocates to the nucleus following antisense treatment. This translocation was observed in cells treated with both exogenous and endogenous antisense, but not in cells treated with the control ODN. Previous work from this laboratory has shown that an RIa antisense ODN inhibits growth in many of those cancer cell types. We postulate that depletion of RIa by antisense treatment promotes the translocation of Ca to the nucleus. This in turn inhibits cancer cell growth by altering the cellular response to growth factors acting through the cAMP pathway. The RIa antisense treatment exerted signi®cant amount of nuclear staining of Ca, beyond optical contamination, re¯ecting an increase of Ca in the nucleus.
Normally, cellular cAMP levels are low and PKA exists as a holoenzyme. In untreated PC3M cells, Ca was seen almost exclusively in the cytoplasm, but there did appear to be low intensity staining of the nucleus. This may re¯ect small amounts of Ca that may be present in the nuclei of rapidly growing malignant cells, or it could re¯ect simple optical contamination. These images are generated by epi¯uorescence, not confocal microscopy, and the view of the nucleus is contaminated by cytoplasm above and below the plane. This can produce some apparent nuclear staining where none exists. Strikingly, after treatment with RIa antisense ODN, there was a signi®cant amount of nuclear staining, which certainly re¯ects an increase in Ca in the nucleus. In contrast, in cells treated with the same concentration of DOTAP with a control ODN instead of RIa antisense ODN, no nuclear translocation of Ca is observed. Therefore, DOTAP itself does not produce any alterations in the cell that would promote translocation of Ca.
In previous work from this laboratory, we have demonstrated that RIa antisense treatment inhibits cell growth. However, this inhibition could simply re¯ect a cellular response to small DNA fragments that may mimic the eect of DNA damage within the cell, activating a mitosis arrest pathway that protects the cells from division while damaged (Schiavone et al., 2000) . The development of a cell line that is stably transfected with RIa antisense gene is therefore crucial to better understand the mechanism by which RIa antisense exerts its eects. The cell line, developed in our laboratory, contains the RIa antisense gene (N-terminal 210 nucleotides of human RIa cDNA in antisense orientation), and thus endogenously express RIa antisense RNA, eliminating the toxic side eects of exogenous ODN (Levin, 1999) . These cells, after induction of the gene by treatment with the heavy metal zinc, show the same altered distribution of Ca as cells treated with exogenous ODN. This con®rms the eect of RIa antisense on the intracellular localization of Ca.
Although RIa antisense induces Ca translocation, it does not do so to the degree that increased cAMP resulting from forskolin activation of adenylate cyclase. RIa antisense may alter the levels of RIa and RIIb, generating a dierentiation signal that halts mitosis and alters the gene expression pro®le of the cell. In this system, some of the excess Ca arising from depletion of RIa would be bound by RIIb, which increases in stability as measured by the protein's half-life . This would explain why only some Ca is free and able to translocate to the nucleus.
In another model system, Dohrman et al. (1996) have demonstrated that ethanol treatment increases cAMP production. Chronic exposure to ethanol desensitizes cells to cAMP and reduces membraneassociated PKA activity. Ethanol also induces translocation of Ca and RIIb to the nucleus, but not by a cAMP-dependent mechanism. This translocation is transient; after removal of ethanol, Ca will return to the cytoplasm (generally the perinuclear region and the Golgi area). This brief nuclear Ca presence may be responsible for the induction of altered gene transcription observed in cells exposed to ethanol (Constantinescu et al., 1999) . The parallels between these two systems (i.e., the ethanol-induced and RIa antisense-induced nuclear translocation of Ca) are obvious; however, it does not mean that the same mechanism occurs in both systems.
In addition to Ca, RIIb may also translocate to the nucleus and modify gene expression (Budillon et al., 1995 , Srivastava et al., 1998 , Tortora and Cho-Chung, 1990 . Ongoing studies in our laboratory will explore this mechanism.
Our results in a cell line overexpressing the RIa antisense gene con®rm the eects of exogenous antisense ODN treatment and demonstrate the ecacy of the modi®cations to the ODN. By chemically altering the ODN to reduce toxicity and other side eects, a very eective, speci®c agent can be generated to downregulate proliferative genes such as RIa. This approach, when used in conjunction with certain traditional chemotherapeutic agents, could provide a speci®c method of control for not only prostate cancer, but other malignancies as well.
Materials and methods
Cell culture PC3M cells were maintained in 100 mm Falcon sterile culture dishes (Becton Dickinson, Franklin Lakes, NJ, USA) in RPMI 1640 medium supplemented with 10% heat-inactivated fetal calf serum, 0.1 mM MEM nonessential amino acids solution, and 1% antibiotic-antimycotic (containing penicillin, streptomycin and amphotericin B; all from Gibco-BRL, Grand Island, NY, USA) (complete RPMI 1640). For immunocytochemistry, cells were plated the day before treatment at 5 000 ± 20 000 per dish in 35 mm Falcon sterile culture dishes (Becton Dickinson) containing ethanol-sterilized 18 mm618 mm glass coverslips (Daigger, Wheeling, IL, USA).
Oligonucleotides
The RIa antisense ODN and control ODN were kindly provided by Dr Sudhir Agrawal. RIa antisense ODN is an RNA-DNA MBO ODN of the sequence 5'-[GCGU]GCCTCCTCAC[UGGC]-3', which contains segments of four 2'-O-methyl-ribonucleosides (RNA) at both the 5' and 3' ends (bracketed) (Nesterova and Cho-Chung, 2000) . The control ODNs used are a 4-base mismatched (underlined) MBO ODN 5'-[GCAU]GCTTCCACA-C[AGGC]-3', and a random sequence oligonucleotide with the sequence 5'-[NNNN]NNNNNNN[NNNN]-3', which also contains RNA at both ends (bracketed), and N=A, T, C or G in a random sequence (Nesterova and Cho-Chung, 2000) . All internucleotide linkages are phosphorothioate.
Oligonucleotide treatment
To increase the delivery of ODN into cells in culture, cationic lipid N-(1-[2,3-dioleoyloxy)propyl]-N,N,N-trimethylammonium methylsulfate (DOTAP) (Roche Molecular Biochemicals, Indianapolis, IN, USA) was used in ODN treatment. The solutions of DOTAP and ODN were prepared in 20 mM HEPES (sterile, Gibco-BRL), then mixed at the ratio of 5 ml DOTAP: 1 mg ODN (manufacturer's protocol) and incubated for 10 min before addition to 1 ml culture medium/35 mm dish. After 10 ± 12 h of seeding, RIa antisense ODN or control ODN was added at various concentrations in the presence of DOTAP. After 24 h of incubation, the medium was removed, fresh medium was added in the absence of ODN and DOTAP, and cells were harvested at the indicated time points. Cells were also treated with DOTAP alone, and no cytotoxicity was observed under the experimental conditions used.
Construction of antisense RIa vector and production of stable transfectants
The N-terminal 210 bp fragment of human PKA RIa cDNA was ampli®ed by PCR using the upstream primer (5'-GCGCGGATCCATGGAGTCTGGCA-3', nucleotide positions 1 to 13) and downstream primer (5'-GCGCG-AATTCTTTCTGCAGATTC-3', nucleotide positions 198 to 210). The PCR product was cut with BamHI/EcoRI and cloned into the EcoRI/BamHI site of the OT1529 retroviral vector (McGeady et al., 1989) in antisense orientation. OT1529 contains the mouse metallothionein (MT-1) promoter as the internal promoter and a gene encoding neomycin phosphotransferase, which confers G418 resistance and allows selection for stable transfectants. Cells were transfected with the MT-RIa antisense vector using the lipofectin method (Gibco-BRL). Stably transfected cells were selected by growing cells in the presence of G418 (400 mg/ml) Gibco-BRL). To induce expression of the antisense RIa gene, cells were treated with 80 mM ZnSO 4 for 3 days.
Antibodies
A mouse monoclonal antibody against the Ca subunit (clone 5B) was obtained from BD Transduction Laboratories (Lexington, KY, USA). A rabbit polyclonal antibody to Ca was obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Both the Cy2-conjugated goat anti-rabbit IgG and the Cy3-conjugated goat anti-mouse IgG were from Jackson ImmunoResearch (West Grove, PA, USA). Cy2 and Cy3 are cyanine dyes, a new generation of¯uorophores. Cy2 (excitation 492 nm, emission 510 nm) is similar to¯uorescein isothiocyanate (FITC), and Cy3 (excitation 550 nm, emission 570 nm) is similar to tetramethyl rhodamine isothiocyanate (TRITC). These¯uorophores are detectable using standard uorescent ®lters for TRITC and FITC (Chroma Inc., Brattleboro, VT, USA). Hoechst 33258 (Sigma) is a nuclear stain that intercalates with DNA and has emission and excitation values in the same range as 4',6-diamidino-2-phenylindole (DAPI).
Immunocytochemistry
All steps were performed at room temperature (258C). Adherent cells on coverslips were washed twice with PBS (BioWhittaker, Walkersville, MD, USA) then ®xed with 3.7% formaldehyde (Mallinckrodt, Paris, KY, USA) for 10 min. After ®xation, coverslips were washed once with PBS and the cells permeabilized with 0.2% Triton X-100 (Sigma) for 10 min. After permeabilization, the coverslips were washed once with an excess of PBS then blocked with a solution of 5% normal goat serum (Sigma) and 1% bovine serum albumin (BSA; Sigma) in PBS for 30 min. The coverslips were once again washed with an excess of PBS then exposed to a solution of the primary antibody in 0.1 M sodium phosphate (SP) buer (pH 7.4) with 1% BSA for 1 h. The coverslips were washed once with PBS and exposed to the secondary antibody in SP buer with 1% BSA for 1 h. The coverslips were washed once with PBS and counterstained with 1 mM Hoechst 33258 (Sigma) in PBS for 15 min. Coverslips were mounted on glass slides (Daigger) with 80% glycerol (Mallinckrodt) in PBS and sealed with nail polish. Slides were viewed with a Zeiss AxioVert 25 CFL microscope (Carl Zeiss, Inc., Thornwood, NY, USA). Images were acquired with a Zeiss Axiophot microscope using Fuji®lm Provia 1600 Professional reversal ®lm (Fuji Photo®lm Co., Ltd., Tokyo, Japan).
